Neogenomics Stock Technical Analysis
| NEO Stock | USD 9.89 0.07 0.71% |
As of the 26th of February, NeoGenomics secures the Risk Adjusted Performance of (0.0009), standard deviation of 2.82, and Mean Deviation of 1.95. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NeoGenomics, as well as the relationship between them.
NeoGenomics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as NeoGenomics, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NeoGenomicsNeoGenomics | Build AI portfolio with NeoGenomics Stock |
NeoGenomics Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 14.81 | Buy | 14 | Odds |
Most NeoGenomics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand NeoGenomics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of NeoGenomics, talking to its executives and customers, or listening to NeoGenomics conference calls.
Will Health Care Providers & Services sector continue expanding? Could NeoGenomics diversify its offerings? Factors like these will boost the valuation of NeoGenomics. Anticipated expansion of NeoGenomics directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every NeoGenomics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.306 | Earnings Share (0.85) | Revenue Per Share | Quarterly Revenue Growth 0.106 | Return On Assets |
Investors evaluate NeoGenomics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating NeoGenomics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause NeoGenomics' market price to deviate significantly from intrinsic value.
It's important to distinguish between NeoGenomics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding NeoGenomics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, NeoGenomics' market price signifies the transaction level at which participants voluntarily complete trades.
NeoGenomics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NeoGenomics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NeoGenomics.
| 11/28/2025 |
| 02/26/2026 |
If you would invest 0.00 in NeoGenomics on November 28, 2025 and sell it all today you would earn a total of 0.00 from holding NeoGenomics or generate 0.0% return on investment in NeoGenomics over 90 days. NeoGenomics is related to or competes with Exagen, MDxHealth, Stereotaxis, Aclaris Therapeutics, Quanterix Corp, Sagimet Biosciences, and Sanara Medtech. NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia More
NeoGenomics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NeoGenomics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NeoGenomics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 18.62 | |||
| Value At Risk | (4.24) | |||
| Potential Upside | 4.99 |
NeoGenomics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for NeoGenomics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NeoGenomics' standard deviation. In reality, there are many statistical measures that can use NeoGenomics historical prices to predict the future NeoGenomics' volatility.| Risk Adjusted Performance | (0.0009) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.40) | |||
| Treynor Ratio | (0.04) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NeoGenomics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
NeoGenomics February 26, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.0009) | |||
| Market Risk Adjusted Performance | (0.03) | |||
| Mean Deviation | 1.95 | |||
| Coefficient Of Variation | (9,394) | |||
| Standard Deviation | 2.82 | |||
| Variance | 7.94 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.40) | |||
| Treynor Ratio | (0.04) | |||
| Maximum Drawdown | 18.62 | |||
| Value At Risk | (4.24) | |||
| Potential Upside | 4.99 | |||
| Skewness | (0.26) | |||
| Kurtosis | 2.96 |
NeoGenomics Backtested Returns
NeoGenomics has Sharpe Ratio of -0.12, which conveys that the firm had a -0.12 % return per unit of risk over the last 3 months. NeoGenomics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify NeoGenomics' Standard Deviation of 2.82, risk adjusted performance of (0.0009), and Mean Deviation of 1.95 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.03, which conveys a somewhat significant risk relative to the market. NeoGenomics returns are very sensitive to returns on the market. As the market goes up or down, NeoGenomics is expected to follow. At this point, NeoGenomics has a negative expected return of -0.31%. Please make sure to verify NeoGenomics' skewness, as well as the relationship between the day median price and relative strength index , to decide if NeoGenomics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.74 |
Almost perfect reverse predictability
NeoGenomics has almost perfect reverse predictability. Overlapping area represents the amount of predictability between NeoGenomics time series from 28th of November 2025 to 12th of January 2026 and 12th of January 2026 to 26th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NeoGenomics price movement. The serial correlation of -0.74 indicates that around 74.0% of current NeoGenomics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.74 | |
| Spearman Rank Test | -0.4 | |
| Residual Average | 0.0 | |
| Price Variance | 1.03 |
NeoGenomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
NeoGenomics Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Normalized Average True Range is used to analyze tradable apportunities for NeoGenomics across different markets.
About NeoGenomics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of NeoGenomics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of NeoGenomics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on NeoGenomics price pattern first instead of the macroeconomic environment surrounding NeoGenomics. By analyzing NeoGenomics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of NeoGenomics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to NeoGenomics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 0.006686 | 0.005943 | Price To Sales Ratio | 0.41 | 0.39 |
NeoGenomics February 26, 2026 Technical Indicators
Most technical analysis of NeoGenomics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for NeoGenomics from various momentum indicators to cycle indicators. When you analyze NeoGenomics charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.0009) | |||
| Market Risk Adjusted Performance | (0.03) | |||
| Mean Deviation | 1.95 | |||
| Coefficient Of Variation | (9,394) | |||
| Standard Deviation | 2.82 | |||
| Variance | 7.94 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.40) | |||
| Treynor Ratio | (0.04) | |||
| Maximum Drawdown | 18.62 | |||
| Value At Risk | (4.24) | |||
| Potential Upside | 4.99 | |||
| Skewness | (0.26) | |||
| Kurtosis | 2.96 |
NeoGenomics February 26, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as NeoGenomics stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.01 | ||
| Daily Balance Of Power | 1.00 | ||
| Rate Of Daily Change | 1.01 | ||
| Day Median Price | 9.86 | ||
| Day Typical Price | 9.87 | ||
| Price Action Indicator | 0.07 | ||
| Market Facilitation Index | 0.07 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeoGenomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. To learn how to invest in NeoGenomics Stock, please use our How to Invest in NeoGenomics guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Will Health Care Providers & Services sector continue expanding? Could NeoGenomics diversify its offerings? Factors like these will boost the valuation of NeoGenomics. Anticipated expansion of NeoGenomics directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every NeoGenomics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.306 | Earnings Share (0.85) | Revenue Per Share | Quarterly Revenue Growth 0.106 | Return On Assets |
Investors evaluate NeoGenomics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating NeoGenomics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause NeoGenomics' market price to deviate significantly from intrinsic value.
It's important to distinguish between NeoGenomics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding NeoGenomics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, NeoGenomics' market price signifies the transaction level at which participants voluntarily complete trades.